Atrial Fibrillation after RSV Vaccination Among Older Adults.

ABSTRACT: RSV vaccine clinical trials reported higher frequencies of atrial fibrillation in intervention groups compared to control. In this large, population-based, propensity-matched study, we found RSV vaccine was not associated with increased risk of new-onset or recurrent atrial fibrillation within 1-42 days compared to influenza or Tdap vaccines.

SUBMITTER: Birabaharan M 

PROVIDER: S-EPMC12302017 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature